Page Image

The Uromigos

The Uromigos, Thomas Powles, MD, and Brian Rini, MD, FASCO, highlight the latest developments in genitourinary cancers. Each podcast episode features a guest expert from around the world discussing the latest data, debates, and manuscripts relevant to the practical clinical care of GU oncology patients.


Latest Episode

Episode 241: Statistics for Clinical Trials and RCC at ASCO 2023
We’re joined by David McDermott, MD, and Meredith Regan, ScD to discuss some of the upcoming RCC presentations at ASCO 2023, as well as how to best interpret KM curves and comparative analysis. Dr. McDermott is a professor of medicine at Harvard Medical School and a physician at Beth Israel Deaconess Medical Center. Dr. Regan is an associate professor of medicine at Dana-Farber Cancer Institute. ...

The Uromigos: Live & Unplugged 2022

Kidney Cancer Discussions

Dr. Brian Rini’s Disclosures

Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis

Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai

Stock: PTC therapeutics